STAMFORD, Conn. (AP) _ Cara Therapeutics Inc. (CARA) on Monday reported a loss of $25.1 million in its second quarter.

The Stamford, Connecticut-based company said it had a loss of 54 cents per share.

The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 68 cents per share.

The biotechnology company posted revenue of $5.6 million in the period, also topping Street forecasts. Four analysts surveyed by Zacks expected $5.5 million.

Cara shares have risen almost 7% since the beginning of the year. In the final minutes of trading on Monday, shares hit $17.22, a drop of 28% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CARA at https://www.zacks.com/ap/CARA

Automated Insights, source Associated Press News